Zafer Pekkolay

745 citations
36 papers · 167 indexed · h-index 7
Topics
Pituitary Gland Disorders and Treatments (9 papers)Growth Hormone and Insulin-like Growth Factors (7 papers)Adrenal and Paraganglionic Tumors (4 papers)

In The Last Decade

Zafer Pekkolay

29 papers receiving 167 citations

Peers

Zafer Pekkolay
Comparison fields: 5 of 45
  • Oncology 64
  • Molecular Biology 55
  • Endocrinology, Diabetes and Metabolism 41
  • Surgery 30
  • Pulmonary and Respiratory Medicine 30
Replace Mitchell S Elkind with:
Mitchell S Elkind United States
Xiaofeng Zou China
Manila Rubino Italy
Fumihiro Uchikoshi Japan
Neha Varshney United States
Linda Piersall United States
P. D. Maaswinkel-Mooy Netherlands
H. P. H. Neumann Germany
Meredith Kato United States
Nicholas Fung Hong Kong
Zafer Pekkolay relative to Mitchell S Elkind United States Mitchell S Elkind's profile →
Citations per field
00.5×10×13×
Mitchell S Elkind · 1×
Citations per year

Countries citing papers authored by Zafer Pekkolay

Since Specialization
Citations

This map shows the geographic impact of Zafer Pekkolay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zafer Pekkolay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zafer Pekkolay more than expected).

Fields of papers citing papers by Zafer Pekkolay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zafer Pekkolay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zafer Pekkolay. The network helps show where Zafer Pekkolay may publish in the future.

Co-authorship network of co-authors of Zafer Pekkolay

This figure shows the co-authorship network connecting the top 25 collaborators of Zafer Pekkolay. A scholar is included among the top collaborators of Zafer Pekkolay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zafer Pekkolay. Zafer Pekkolay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 7
4 1
5 3
6 2
7 3
8 12
9 1
10 3
11 0
12 2
13 1
14 8
15 1
16 6
17 15
18 2
19
Contribution of low-molecular weight heparin addition to concomitant chemoradiotherapy in the treatment of glioblastoma multiforme.
6
20 54

About Zafer Pekkolay

Zafer Pekkolay is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Ophthalmology, having authored 36 papers that have together received 167 indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (9 papers), Growth Hormone and Insulin-like Growth Factors (7 papers) and Adrenal and Paraganglionic Tumors (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (41 citations), Oncology (64 citations) and Ophthalmology (18 citations). Zafer Pekkolay has collaborated with scholars based in Türkiye, United States and Colombia. Frequent co-authors include Faruk Kılınç, Zuhat Urakçı, Ali̇ İnal, Uğur Fırat, Alpaslan Tuzcu, Abdurrahman Işıkdoğan, Kaplan Ma, Mehmet Küçüköner, Nevzat Gözel and Ebru Önalan Etem. Their work appears in journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026